Jasper Ridge Partners, L.P. 10x Genomics, Inc. Transaction History
Jasper Ridge Partners, L.P.
- $3.1 Billion
- Q1 2025
A detailed history of Jasper Ridge Partners, L.P. transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Jasper Ridge Partners, L.P. holds 39,457 shares of TXG stock, worth $552,398. This represents 0.01% of its overall portfolio holdings.
Number of Shares
39,457
Previous 39,457
-0.0%
Holding current value
$552,398
Previous $566,000
39.22%
% of portfolio
0.01%
Previous 0.02%
Shares
11 transactions
Others Institutions Holding TXG
# of Institutions
303Shares Held
110MCall Options Held
228KPut Options Held
157K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl12.8MShares$180 Million1.21% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.1MShares$156 Million0.0% of portfolio
-
Ubs Asset Management Americas Inc Chicago, IL7.1MShares$99.5 Million0.02% of portfolio
-
Black Rock Inc. New York, NY6.39MShares$89.5 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny5.38MShares$75.3 Million0.03% of portfolio
About 10x Genomics, Inc.
- Ticker TXG
- Exchange NASDAQ
- Sector Healthcare
- Industry Health Information Services
- Shares Outstandng 95,046,400
- Market Cap $1.33B
- Description
- 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...